BioTime's use of HyStem in the medical-aesthetics market will lead to near-term revenues and potential profits, while advancing its therapeutic stem cell platform.
http://ift.tt/1jXTztn
http://ift.tt/1jXTztn
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment